The big risk is not that AI makes Vistra obsolete; it is that the market has moved faster than the operating and regulatory timetable. If
Cogentrix closes on time, nuclear volumes ramp as planned, and scarce
firm power stays scarce, the equity can compound well. If approvals slip, outages rise, or power scarcity normalizes sooner, the stock can behave like a volatile
merchant generator again.